Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: Diagnostic considerations for mucopolysaccharidoses

JIMD Reports

Volumn 11, Issue , 2013, Pages 125-132

  Mendelsohn, Nancy J ^a,b   Wood, Timothy ^c   Olson, Rebecca A ^a   Temme, Renee ^a   Hale, Susan ^d   Zhang, Haoyue ^e   Read, Lisa ^a   White, Klane K ^d  

^a Childrens Hospitals and Clinics of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c GREENWOOD GENETIC CENTER   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dermatan sulfate; Enzyme replacement therapy; Multiple sulfatase deficiency; Spondyloepiphyseal dysplasia; Stickler syndrome

Indexed keywords

EID: 84893797099     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2013_231     Document Type: Chapter

References (36)

1. Alder A (1939) Ueber konstitutionell bedingte Granulationsveraender-ungen der Leukocyten. Dtsch Arch Klin Med 183:372–378
2. Andersen PE Jr, Schantz K, Bollerslev J, Justesen P (1988) Bilateral femoral head dysplasia and osteochondritis. Multiple epiphyseal dysplasia tarda, spondylo-epiphyseal dysplasia tarda, and bilateral Legg-Perthes disease. Acta Radiol 29(6):705–709
3. Baum H, Dodgson KS, Spencer B (1959) The assay of arylsulphatases A and B in human urine. Clinica Chimica Acta 4:453–455
4. Bunge S, Kleijer WJ, Tylki-Szymanska A, Steglich C, Beck M, Tomatsu S et al (1997) Identification of 31 novel mutations in the N-Acetylgalactosamine-6-Sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome. Hum Mutat 10(3):223–232
5. Crossan JF, Wynne-Davies R, Fulford GE (1983) Bilateral failure of the capital femoral epiphysis: bilateral Perthes disease, multiple epiphyseal dysplasia, pseudoachondroplasia, and spondyloepiphyseal dysplasia congenita and tarda. J Pediatr Orthop 3:297–301
6. de Jong JG, Wevers RA, Laarakkers C et al (1989) Dimethyl-methylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem 35:1472–1477
7. Dembure PP, Roesel RA (1991) Screening for mucopolysaccharidoses by analysis of urinary glycosaminoglycans. In: Hommes F (ed) Techniques in diagnostic human biochemical genetics: a laboratory manual. Wiley-Liss, New York, pp 77–86
8. Dorfman A, Matalon R (1976) The mucopolysaccharidosis. Proc Natl Acad Sci USA 73:630
9. Fang-Kircher SG, Bock A, Fertschak W, Schwager W, Paschke E (1995) Morquio disease in a patient diagnosed as having Perthes disease for 38 years. J Inher Metab Dis 18:94–95
10. Gottwald I, Hughes J, Stewart F, Tylee K, Church H, Jones SA (2011) Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the pY210C mutation in the ARSB gene. Mol Genet Metab 103(3):300–302
11. Gray G, Claridge P, Jenkinson L et al (2007) Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: an evaluation. Ann Clin Biochem 44:360–363
12. Guille JT, Lipton GE, Tsirikos AI, Bowen JR (2002) Bilateral Legg-Calvé-Perthes disease: presentation and outcome. J Pediatr Orthop 22:458–463
13. Hecht JT, Scott CL Jr, Smith TK et al (Jun 1984) Mild manifestations of the Morquio syndrome. Am J Med Genet 18(2):369–371
14. Hopwood JJ, Harrison JR (1982) High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal Biochem 119:120–127
15. Karageoros L, Brooks D, Pollard A et al (2007) Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat 28 (9):897–903
16. Kato Z, Fukuda S, Tomatsu S et al (1997) A novel common missense mutation G301C in the N-acetylgalactosamine-6-sulfate sulfatase gene in mucopolysaccharidosis IVA. Hum Genet 101(1):97–101
17. Kim HK (2011) Legg-Calvé Perthes disease: etiology, pathogenesis, and biology. J Pediatr Orthop 31(Supp 2):S141–S146
18. Krabbi K, Joost K, Zordania R et al (2012) The live-birth prevalence of mucopolysaccharidoses in Estonia. Genet Test Mol Bio-markers 16(8):846–849 (Epub ahead of print)
19. Litjens T, Brooks DA, Peters C, Gibson GJ, Hopwood JJ (1996) Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet 58:1127–1134
20. Maroteaux P, Leveque B, Marie J, Lamy M (1963) A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med 71:1849–1852
21. McKusick VA (1972) Heritable disorders of connective tissue. C.V. Mosby, St. Louis, MO, pp 525, 611
22. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254
23. Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T (2007) International Morquio a registry: clinical manifestations and natural course of Morquio A disease. J Inherit Metab Dis 30:165–174
24. Morquio L (1929) Sur une forme de dystrophie osseuse familial. Arch de médecine des infants 32:129–135
25. Paterson DE, Harper G, Weston HJ et al (1982) Maroteaux Lamy syndrome, mild form – MPS VI B. Br J Radiol 55:805–812
26. Prat C, Lemaire O, Bret J, Zabraniecki L, Fournie B (2008) Morquio syndrome: diagnosis in an adult. Joint Bone Spine 75:495–498
27. Stone J (1998) Urine analysis in the diagnosis of mucopolysaccharide disorders. Ann Clin Biochem 35(Pt 2):207–225
28. Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effects of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet 134A:144–150
29. Tomatsu S, Montano AM, Nishioka T et al (2005) Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26:500–512
30. Tønnesen T, Gregersen HN, Guttler F (1991) Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux Lamy phenotype. J Med Genet 28:499–501
31. Tylki-Szymanska A, Czartoryska B, Bunge S et al (1998) Clinical, biochemical and molecular findings in a two-generation Morquio A family. Clin Genet 53(5):369–374
32. Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5
33. van Diggelen OP, Zhao H, Kleijer WJ et al (1990) A fluorimetric enzyme assay for the diagnosis of Morquio disease type A. Clin Chem Acta 187:131–140
34. Wood T, Bodamer OA, Burin MG et al (2012) Expert recommendations for the laboratory diagnosis of MPS VI. Mol Genet Metab 106(1):73–82
35. Zhang H (2012) Analysis of glycosaminoglycans in CSF and urine using tandem mass spectrometry: Potential for therapeutic monitoring of patients with mucopolysaccharidoses. Jrnl Amer Soc Mass Spec 22(1):66
36. Zhang H, Young SP, Auray-Blais C, Orchard PJ, Tolar J, Millington DS (2011) Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquids chromatography-tandem mass spectrometry. Clin Chem 57(7):1005–1012